Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells

Carcinogenesis

Volumn 29, Issue 9, 2008, Pages 1692-1700

  Dubi, Noga ^a   Gheber, Larisa ^a   Fishman, Daniel ^a   Sekler, Israel ^a   Hershfinkel, Michal ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CALCIUM; G PROTEIN COUPLED RECEPTOR; INOSITOL PHOSPHATE; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE B; RECEPTOR; UNCLASSIFIED DRUG; ZINC; ZINC CITRATE; ZINC SENSING RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM DEPLETION; CANCER CELL; CELL GROWTH; CELL STRAIN LNCAP; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FLUORESCENCE; HUMAN; HUMAN CELL; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; FURA-2; HUMANS; IMMUNOBLOTTING; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; ZINC COMPOUNDS;

EID: 51849108493     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn027     Document Type: Article

References (54)

1. Sorensen,M.B. et al. (1997) Ultrastructural localization of zinc ions in the rat prostate: An autometallographic study. Prostate, 31, 125-130.
2. Costello,L.C. et al. (2006) The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: Connecting the dots. Mol. Cancer, 5, 17.
3. Costello,L.C. et al. (2000) The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy. Oncology, 59, 269-82.
4. Costello,L.C. et al. (1999) Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J. Biol. Chem, 274, 17499-17504.
5. Franklin,R.B. et al. (2003) Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J. Inorg. Biochem, 96, 435-442.
6. Singh,K.K. et al. (2006) Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol. Cancer, 5, 14.
7. Tsui,K.H. et al. (2006) Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells. Int. J. Cancer, 118, 609-615.
8. Costello,L.C. et al. (1998) Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate, 35, 285-296.
9. Untergasser,G. et al. (2000) High levels of zinc ions induce loss of mitochondrial potential and degradation of antiapoptotic Bcl-2 protein in in vitro cultivated human prostate epithelial cells. Biochem. Biophys. Res. Commun, 279, 607-614.
10. Wong,Y.C. et al. (2000) Changes in serum and tissue zinc levels in sex hormone-induced prostatic carcinogenesis in the noble rat. Tumour Biol, 21, 328-336.
11. Magda,D. et al. (2005) Motexatin gadolinium disrupts zinc metabolism in human cancer cell lines. Cancer Res, 65, 3837-3845.
12. Huang,L. et al. (2006) Decreased intracellular zinc in human tumorigenic prostate epithelial cells: A possible role in prostate cancer progression. Cancer Cell Int, 6, 10.
13. Uzzo,R.G. et al. (2006) Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: Implications for prostate cancer progression. Carcinogenesis, 27, 1980-1990.
14. Azriel-Tamir,H. et al. (2004) Extracellular zinc triggers ERK-dependent activation of Na+/H+ exchange in colonocytes mediated by the zinc-sensing receptor. J. Biol. Chem, 279, 51804-51816.
15. Huang,J.S. et al. (1999) Extracellular calcium stimulates DNA synthesis in synergism with zinc, insulin and insulin-like growth factor I in fibroblasts. Eur. J. Biochem, 266, 943-951.
16. Kiss,Z. et al. (1997) Bombesin and zinc enhance the synergistic mitogenic effects of insulin and phosphocholine by a MAP kinase-dependent mechanism in Swiss 3T3 cells. FEBS Lett, 415 71-74.
17. Wu,W. et al. (2005) p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression. Am. J. Physiol. Lung Cell Mol. Physiol, 289, L883-L889.
18. Kim, Y.M. et al. (2006) Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol, 290, L1028-L1035.
19. Kim,S. et al. (2000) Extracellular zinc activates p70 S6 kinase through the phosphatidylinositol 3-kinase signaling pathway. J. Biol. Chem, 275, 25979-25984.
20. An,W.L. et al. (2005) Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2. Brain Res. Mol. Brain Res, 135, 40-47.
21. Ostrakhovitch,E.A. et al. (2005) Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF) mediated apoptosis in epithelial breast cancer cells: The lack of effect of ERK in p53 mediated copper induced apoptosis. J. Cell Biochem, 95, 1120-1134.
22. Hershfinkel,M. et al. (2001) A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc. Natl Acad. Sci. USA, 98, 11749-11754.
23. Sharir,H. et al. (2005) The extracellular zinc-sensing receptor mediates intercellular communication by inducing ATP release. Biochem. Biophys. Res. Commun, 332, 845-852.
24. Milon,B. et al. (2006) Histidine residues in the region between transmembrane domains III and IV of hZip1 are required for zinc transport across the plasma membrane in PC-3 cells. Biochim. Biophys. Acta, 1758, 1696-1701.
25. Priel,T. et al. (2006) Zinc influx and physiological consequences in the beta-insulinoma cell line, Min6. Biochem. Biophys. Res. Commun 346, 205-212.
26. Skehan,P. et al. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst, 82, 1107-1112.
27. Taniguchi,M. et al. (2004) YM-254890 analogues, novel cyclic depsipeptides with Galpha(q/11) inhibitory activity from Chromobacterium sp. QS3666. Bioorg. Med. Chem, 12, 3125-3133.
28. Narayanan,B.A. et al. (2006) Adenocarcina of the mouse prostate growth inhibition by celecoxib: Downregulation of transcription factors involved in COX-2 inhibition. Prostate, 66, 257-265.
29. McCubrey,J.A. et al. (2006) Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta, 1773, 1263-1284.
30. Hassan,S. et al. (2004) Involvement of MAP-kinase, PI3 -kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. Regul. Pept, 120, 155-166.
31. Gavrielides,M.V. et al. (2004) Protein kinase C and prostate carcinogenesis: Targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets, 5, 431-443.
32. Feng,P. et al. (2002) Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate, 52, 311-318.
33. van Bokhoven,A. et al. (2003) Molecular characterization of human prostate carcinoma cell lines. Prostate, 57, 205-225.
34. van Bokhoven,A. et al. (2001) Widely used prostate carcinoma cell lines share common origins. Prostate, 47, 36-51.
35. Yin,L. et al. (2005) Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway. J. Biol. Chem, 280, 5533-5541.
36. Park,K.S. et al. (2003) The ERK pathway involves positive and negative regulations of HT29 colorectal cancer cell growth by extracellular zinc. Am. J. Physiol. Gastrointest. Liver Physiol, 285, G1181-G1188.
37. Iguchi,K. et al. (2004) Zinc and metallothionein levels and expression of zinc transporters in androgen-independent subline of LNCaP cells. J. Androl, 25, 154-161.
38. Iguchi,K. et al. (2007) Isolation and characterization of LNCaP sublines differing in hormone sensitivity. J. Androl, 28, 670-678.
39. Liang,J.Y. et al. (1999) Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate, 40, 200-207.
40. Franklin,R.B. et al. (2005) Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer. Front. Biosci, 10, 2230-2239.
41. Aizenman,E. et al. (2000) Induction of neuronal apoptosis by thiol oxidation: Putative role of intracellular zinc release. J. Neurochem 75, 1878-1888.
42. Ovesen,J. et al. (2004) Autometallographic tracing of zinc ions in growing bone. J. Musculoskelet. Neuronal Interact, 4, 428-435.
43. Barak,L.S. et al. (2003) Constitutive desensitization: A new paradigm for g protein-coupled receptor regulation. Assay Drug Dev. Technol, 1, 339-346.
44. Maudsley,S. et al. (2005) The origins of diversity and specificity in g protein-coupled receptor signaling. J. Pharmacol. Exp. Ther, 314, 485-494.
45. Uzgare,A.R. et al. (2004) Enhanced redundancy in Akt and mitogenactivated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Cancer Res, 64, 6190-6199.
46. Bertram,J. et al. (2006) Inhibition of the phosphatidylinositol 3′-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. Cancer Res, 66, 4781-4788.
47. Liao,Z. et al. (2005) Increased phospho-AKT is associated with loss of the androgen receptor during the progression of N methyl-N-nitrosoureainduced prostate carcinogenesis in rats. Prostate, 64, 186-199.
48. Lee,J.T. Jr et al. (2004) Phosphatidylinositol 3′-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells. Cancer Res, 64, 8397-8404.
49. Li,X. et al. (2007) Activation of extracellular signal-regulated kinase by 12-hydroxyheptadecatrienoic acid in prostate cancer PC3 cells. Arch. Biochem. Biophys, 467, 20-30.
50. Chen,J. et al. (2007) Niaspan increases angiogenesis and improves functional recovery after stroke. Ann. Neurol, 7, 7.
51. Park,K.S. et al. (2002) Extracellular zinc stimulates ERK-dependent activation of p21(Cip/WAF1) and inhibits proliferation of colorectal cancer cells. Br. J. Pharmacol, 137, 597-607.
52. Tanaka,Y. et al. (2003) Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem, 278, 33753-33762.
53. Stewart,J.R. et al. (2005) Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells. Mol. Cancer Ther, 4, 726-732.
54. Oh,S.Y. et al. (2002) Differential modulation of zinc-stimulated p21(Cip/WAF1) and cyclin D1 induction by inhibition of PI3 kinase in HT-29 colorectal cancer cells. Exp. Mol. Med, 34, 27-31.